Showing results (61-70 of 70) with videos related to
Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
The Journal of Experimental Medicine|April 19, 2000
Infectious agents are not necessary for murine atherogenesisS D Wright, C Burton, M Hernandez, et al.Transgenic Research|November 1, 2011
Metabolic syndrome in mice induced by expressing a transcriptional activator in adipose tissueLiwen Zhang, Yuchen Zhou, Amber Ying Zhu, et al.Virus Genes|December 17, 2011
Comparative full genome analysis of four infectious laryngotracheitis virus (Gallid herpesvirus-1) virulent isolates from the United StatesS J Spatz, J D Volkening, C L Keeler, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|January 9, 2001
Simvastatin has anti-inflammatory and antiatherosclerotic activities independent of plasma cholesterol loweringC P Sparrow, C A Burton, M Hernandez, et al.Bioorganic & Medicinal Chemistry Letters|September 28, 2005
Discovery of 4-heteroarylbicyclo[2.2.2]octyltriazoles as potent and selective inhibitors of 11beta-HSD1: novel therapeutic agents for the treatment of metabolic syndromeXin Gu, Jasminka Dragovic, Gloria C Koo, et al.Biochemical and Biophysical Research Communications|December 19, 2000
PPARalpha agonists reduce 11beta-hydroxysteroid dehydrogenase type 1 in the liverA Hermanowski-Vosatka, D Gerhold, S S Mundt, et al.Bioorganic & Medicinal Chemistry Letters|April 25, 2008
Bis-aryl triazoles as selective inhibitors of 11beta-hydroxysteroid dehydrogenase type 1Susan D Aster, Donald W Graham, Divya Kharbanda, et al.Bioorganic & Medicinal Chemistry Letters|July 26, 2005
Adamantyl triazoles as selective inhibitors of 11beta-hydroxysteroid dehydrogenase type 1Steven Olson, Susan D Aster, Kai Brown, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 7, 2000
Deficiency in inducible nitric oxide synthase results in reduced atherosclerosis in apolipoprotein E-deficient miceP A Detmers, M Hernandez, J Mudgett, et al.The Journal of Experimental Medicine|August 17, 2005
11beta-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in miceAnne Hermanowski-Vosatka, James M Balkovec, Kang Cheng, et al.Pageof 7